Terms: = Ovarian cancer AND TRRAP, TR-AP, 8295, ENSG00000196367, Q9Y4A5, PAF400, PAF350/400, FLJ10671, STAF40, Tra1
771 results:
1. Plasma metabolites and risk of seven cancers: a two-sample Mendelian randomization study among European descendants.
Chen Y; Xie Y; Ci H; Cheng Z; Kuang Y; Li S; Wang G; Qi Y; Tang J; Liu D; Li W; Yang Y
BMC Med; 2024 Mar; 22(1):90. PubMed ID: 38433226
[TBL] [Abstract] [Full Text] [Related]
2. The IGF-PAPP-A-Stanniocalcin Axis in Serum and Ascites Associates with Prognosis in Patients with ovarian cancer.
Hjortebjerg R; Høgdall C; Hansen KH; Høgdall E; Frystyk J
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396692
[TBL] [Abstract] [Full Text] [Related]
3. Paeonol impacts ovarian cancer cell proliferation, migration, invasion and apoptosis via modulating the transforming growth factor beta/smad3 signaling pathway.
Chen XM; Jia CL; Zhu ZY
J Physiol Pharmacol; 2023 Dec; 74(6):. PubMed ID: 38345445
[TBL] [Abstract] [Full Text] [Related]
4. [Killing effect of anti-MSLN-iCAR-NK cells derived from induced pluripotent stem cells on ovarian epithelial cancer cells].
Fan RJ; Zhang YF; Wang YY; Wang Y; Zheng W
Zhonghua Fu Chan Ke Za Zhi; 2023 Dec; 58(12):922-929. PubMed ID: 38123198
[No Abstract] [Full Text] [Related]
5. Genomic hypomethylation in cell-free DNA predicts responses to checkpoint blockade in lung and breast cancer.
Kim K; Kim H; Shin I; Noh SJ; Kim JY; Suh KJ; Kim YN; Lee JY; Cho DY; Kim SH; Kim JH; Lee SH; Choi JK
Sci Rep; 2023 Dec; 13(1):22482. PubMed ID: 38110532
[TBL] [Abstract] [Full Text] [Related]
6. Genome-wide association study meta-analysis of dizygotic twinning illuminates genetic regulation of female fecundity.
Mbarek H; Gordon SD; Duffy DL; Hubers N; Mortlock S; Beck JJ; Hottenga JJ; Pool R; Dolan CV; Actkins KV; Gerring ZF; Van Dongen J; Ehli EA; Iacono WG; Mcgue M; Chasman DI; Gallagher CS; Schilit SLP; Morton CC; Paré G; Willemsen G; Whiteman DC; Olsen CM; Derom C; Vlietinck R; Gudbjartsson D; Cannon-Albright L; Krapohl E; Plomin R; Magnusson PKE; Pedersen NL; Hysi P; Mangino M; Spector TD; Palviainen T; Milaneschi Y; Penninnx BW; Campos AI; Ong KK; Perry JRB; Lambalk CB; Kaprio J; Ólafsson Í; Duroure K; Revenu C; Rentería ME; Yengo L; Davis L; Derks EM; Medland SE; Stefansson H; Stefansson K; Del Bene F; Reversade B; Montgomery GW; Boomsma DI; Martin NG
Hum Reprod; 2024 Jan; 39(1):240-257. PubMed ID: 38052102
[TBL] [Abstract] [Full Text] [Related]
7. A comprehensive prognostic analysis of cause-specific mortality in patients with ovarian serous cystadenocarcinoma using a competing-risks model: a case study of the SEER database.
Chong SM; Li YJ; He Y; Chokkakula S; Ming WK; Leong NC; Zhao QQ; Chen WH; Huang CD; Deng LH; Lyu J
Eur Rev Med Pharmacol Sci; 2023 Nov; 27(22):11143-11155. PubMed ID: 38039046
[TBL] [Abstract] [Full Text] [Related]
8. The role of non-genomic actions of progesterone and its membrane receptor agonist in ovarian cancer cell death.
Koyanagi T; Saga Y; Takahashi Y; Tamura K; Yoshiba T; Takahashi S; Taneichi A; Takei Y; Mizukami H; Fujiwara H
Cancer Rep (Hoboken); 2024 Jan; 7(1):e1934. PubMed ID: 38013666
[TBL] [Abstract] [Full Text] [Related]
9. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in patients with ovarian cancer: A systematic review.
Taliento C; Restaino S; Scutiero G; Arcieri M; Bernardi G; Martinello R; Driul L; Perrone AM; Fagotti A; Scambia G; Greco P; Vizzielli G
Eur J Surg Oncol; 2023 Dec; 49(12):107250. PubMed ID: 37951158
[TBL] [Abstract] [Full Text] [Related]
10. Combined Bilateral Salpingo-oophorectomy and Cesarean Delivery in BRCA1/2 Alteration Carriers : A Case Series.
Barker VE; Vlachodimitropoulou E; O'Brien P; Iskaros J; Rosenthal AN
Obstet Gynecol; 2023 Dec; 142(6):1500-1503. PubMed ID: 37917945
[TBL] [Abstract] [Full Text] [Related]
11. The effect of growth hormone on ovarian function recovery in a mouse model of ovarian insufficiency.
Kim SM; Yoo JY; Hong YH; Lee J; Kim JH; Lee JR
Front Endocrinol (Lausanne); 2023; 14():1184977. PubMed ID: 37854196
[TBL] [Abstract] [Full Text] [Related]
12. Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer.
Chen B; Ding X; Wan A; Qi X; Lin X; Wang H; Mu W; Wang G; Zheng J
Sci Rep; 2023 Sep; 13(1):16244. PubMed ID: 37758722
[TBL] [Abstract] [Full Text] [Related]
13. Association of pre-diagnosis specific color groups of fruit and vegetable intake with ovarian cancer survival: results from the ovarian cancer follow-up study (OOPS).
Liu YY; Gong TT; Li YZ; Xu HL; Zheng G; Liu FH; Qin X; Xiao Q; Wu QJ; Huang DH; Gao S; Zhao YH
Food Funct; 2023 Sep; 14(18):8442-8452. PubMed ID: 37622277
[No Abstract] [Full Text] [Related]
14. A Phase Ib, Open-label Study Evaluating the Safety and Efficacy of Ipatasertib plus Rucaparib in Patients with Metastatic Castration-resistant Prostate cancer.
Pook D; Geynisman DM; Carles J; de Braud F; Joshua AM; Pérez-Gracia JL; Llácer Pérez C; Shin SJ; Fang B; Barve M; Maruzzo M; Bracarda S; Kim M; Kerloeguen Y; Gallo JD; Maund SL; Harris A; Huang KC; Poon V; Sutaria DS; Gurney H
Clin Cancer Res; 2023 Sep; 29(17):3292-3300. PubMed ID: 37339186
[TBL] [Abstract] [Full Text] [Related]
15. Progression-free survival and safety at 3.5years of follow-up: results from the randomised phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer.
González-Martín A; Pothuri B; Vergote I; Graybill W; Lorusso D; McCormick CC; Freyer G; Backes F; Heitz F; Redondo A; Moore RG; Vulsteke C; O'Cearbhaill RE; Malinowska IA; Shtessel L; Compton N; Mirza MR; Monk BJ
Eur J Cancer; 2023 Aug; 189():112908. PubMed ID: 37263896
[TBL] [Abstract] [Full Text] [Related]
16. Microsatellite instability in non-endometrioid ovarian epithelial tumors: a study of 400 cases comparing immunohistochemistry, PCR, and NGS based testing with mutation status of MMR genes.
Hájková N; Bártů MK; Cibula D; Drozenová J; Fabian P; Fadare O; Frühauf F; Hausnerová J; Hojný J; Krkavcová E; Laco J; Lax SF; Matěj R; Méhes G; Michálková R; Němejcová K; Singh N; Stolnicu S; Švajdler M; Zima T; McCluggage WG; Stružinská I; Dundr P
Transl Res; 2023 Oct; 260():61-68. PubMed ID: 37244485
[TBL] [Abstract] [Full Text] [Related]
17. Pathogenesis of endometrium-related diseases based on genomic alterations in normal uterine endometrium.
Yoshihara K
J Obstet Gynaecol Res; 2023 Aug; 49(8):2023-2030. PubMed ID: 37226598
[TBL] [Abstract] [Full Text] [Related]
18. Role of PARP inhibitors beyond BRCA mutation and platinum sensitivity in epithelial ovarian cancer: a meta-analysis of hazard ratios from randomized clinical trials.
Purwar R; Ranjan R; Pal M; Upadhyay SK; Kumar T; Pandey M
World J Surg Oncol; 2023 May; 21(1):157. PubMed ID: 37217940
[TBL] [Abstract] [Full Text] [Related]
19. Supervised resistance exercise for women with ovarian cancer who have completed first-line treatment: a pragmatic study.
Schofield C; Newton RU; Taaffe DR; Galvão DA; Cohen PA; Meniawy TM; Peddle-McIntyre CJ
Support Care Cancer; 2023 Apr; 31(5):304. PubMed ID: 37101013
[TBL] [Abstract] [Full Text] [Related]
20. [Olaparib Could Be Re-Administered after Chemotherapy].
Terasawa R; Takashima Y; Hirata A; Kimura K; Morita S; Hayashi M
Gan To Kagaku Ryoho; 2023 Apr; 50(4):473-475. PubMed ID: 37066460
[TBL] [Abstract] [Full Text] [Related]
[Next]
